Trump announces reforms to accelerate access to psychedelic drug treatments
Briefly

Trump announces reforms to accelerate access to psychedelic drug treatments
"Trump signed an executive order directing the FDA to expedite review of drugs such as ibogaine, which US military veteran groups have said can help treat post-traumatic stress disorder."
"The US would dedicate $50 million to federal research into ibogaine, which is made from a central African shrub root and has shown potential to treat opioid and other substance abuse problems."
"If these turn out to be as good as people are saying, it's going to have a tremendous impact on this country and other countries, too."
Donald Trump signed an executive order to expedite the FDA's review of psychedelic drugs like ibogaine, which may help treat PTSD. The reforms aim to reclassify these drugs after successful clinical trials. Trump announced a $50 million federal research commitment to ibogaine, which has potential benefits for opioid and substance abuse treatment. The initiative is expected to particularly benefit Texas, which has also allocated $50 million for ibogaine research. Trump expressed optimism about the impact of these drugs on the country and beyond.
Read at www.theguardian.com
Unable to calculate read time
[
|
]